Pharmaceuticals

Roxadustat Market Developments And Opportunities Across 2026–2030

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Roxadustat Market In 2026, And How Will Its Value Evolve By 2030?

The roxadustat market size has experienced substantial expansion over recent years. Forecasts indicate it will expand from $6.86 billion in 2025 to $7.33 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.9%. Historically, this growth can be attributed to factors such as the high prevalence of chronic kidney disease, the dependence on erythropoiesis-stimulating agents, hospital-based anemia management, the limited availability of oral anemia therapies, and an increase in dialysis centers.

The roxadustat market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach a valuation of $9.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This forecasted growth is primarily driven by factors such as the increasing global prevalence of anemia, a growing inclination towards oral treatment options, the expanding population of chronic kidney disease (CKD) patients, the advancement of outpatient anemia care, and enhanced availability of novel anemia medications. Key trends anticipated during this period encompass the wider acceptance of oral anemia treatments, an increase in the utilization of HIF-PHI drugs, a heightened emphasis on anemia linked to CKD, a transition from injectable erythropoiesis-stimulating agents (ESAs), and broadened access to anemia therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21280&type=smp

What Key Factors Are Affecting The Roxadustat Market Demand?

An increasing prevalence of chronic kidney disease (CKD) is anticipated to drive the expansion of the Roxadustat market moving ahead. This condition, CKD, involves a progressive decline in kidney function over an extended period, frequently resulting in renal failure without proper intervention. The global count of individuals impacted by chronic kidney disease is escalating, attributed to elements like an aging global populace, a surge in diabetes and hypertension rates, and lifestyle choices that are not conducive to health. Roxadustat aids in the management of chronic kidney disease by encouraging erythropoietin production, thereby boosting red blood cell generation and mitigating anemia, a frequent complication of CKD. This action ultimately enhances overall kidney function and improves the quality of life for patients. For example, data from June 2023, provided by the UK-based charity Kidney Research UK, indicates a projected increase to 3.9 million individuals with CKD stages 3–5 by the year 2033. Consequently, the growing population affected by chronic kidney disease (CKD) is fueling the expansion of the Roxadustat market.

Which Segment Classifications Are Used In The Roxadustat Market Segment Analysis?

The roxadustat market covered in this report is segmented –

1) By Type: 20mg, 50mg

2) By Product Formulation: Oral Tablets

3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers

4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions

What Emerging Trends Are Seen In The Roxadustat Market?

Major companies within the roxadustat market are focusing on producing real-world evidence, such as observational registry studies, to validate the enduring value, safety, and usage patterns of their HIF PH inhibitor therapy. Real-world evidence refers to clinical data gathered outside controlled trials, within routine practice environments, to reflect actual patient experiences. The roxadustat market supports this movement by sponsoring extensive real-world studies that healthcare payers and regulators increasingly depend on for evaluation. For instance, in May 2024, Astellas Pharma, a UK-based company, completed the launch of the WINE study via the WiNe Registry in Germany, which is a non-interventional cohort study collecting clinical outcomes, dosing characteristics, and hemoglobin response in patients treated with EVRENZO (roxadustat). The insights gained from that registry assist in demonstrating roxadustat’s effectiveness in real-world CKD populations and support long-term reimbursement determinations. As a result, the generation of real-world evidence is propelling the expansion of the roxadustat market.

Which Firms Are Contributing To The Roxadustat Market Ecosystem?

Major companies operating in the roxadustat market are AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy’s Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd.

Get The Full Roxadustat Market Report:

https://www.thebusinessresearchcompany.com/report/roxadustat-global-market-report

Which Region Is The Largest In The Roxadustat Market?

North America was the largest region in the Roxadustat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the roxadustat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Roxadustat Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/roxadustat-global-market-report

Browse Through More Reports Similar to the Global Roxadustat Market 2026, By The Business Research Company

Rotavators Market Report 2026

https://www.thebusinessresearchcompany.com/report/rotavators-global-market-report

Vermiculite Market Report 2026

https://www.thebusinessresearchcompany.com/report/vermiculite-global-market-report

Agritech Market Report 2026

https://www.thebusinessresearchcompany.com/report/agritech-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795